The phase III REDEFINE 1 study results, released in December 2024, showed that the CagriSema treatment group lost 22.7% of their weight after 68 weeks, significantly outperforming the single-target control drugs (semaglutide group lost 16.1%, cagrilintide group lost 11.8%)
While constipation itself isn't directly predicted, your genetic profile reveals how your body's appetite and metabolic regulation systems respond, informing which GLP-1 formulation and dosing strategy may work best for your body
Over-the-counter anti-nausea medications like ondansetron (Zofran) can provide temporary relief during the first 24 weeks, though your doctor should approve their use
Effect of a long-acting somatostatin analog (SMS 201995) on postprandial gastric emptying of 99m Tctin colloid and mouth-to-caecum transit time in man
Semaglutide helps people of virtually every age, size and lifestyle lose weight by improving insulin resistance to accelerate fat usage, rather than storage
More rare but serious risks include pancreatitis and thyroid tumors, particularly in individuals with pre-existing risk factors, such as a family history of medullary thyroid carcinoma
